Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced the launch of Ultherapy PRIME – a noninvasive, FDA-cleared medical aesthetics treatment that provides a truly personalized and long-lasting lift of the skin in one session with zero downtime.

The Ultherapy PRIME platform is the evolution of Ultherapy, which has been recognized as the Gold Standard for nonsurgical lifting due to its large body of clinical evidence, well-established mechanism of action (MOA) and high patient satisfaction. Built on a legacy of proven, natural-looking outcomes, Ultherapy PRIME redefines the future of nonsurgical skin lifting by uniquely combining advanced ultrasound technology, vivid real-time imaging and proven results. These advancements promote long-lasting results paired with healthier-looking skin.

The platform's modern design and advanced operating system deliver 20% faster treatments, elevated ergonomics, and more efficient workflows for aesthetic health care professionals. Ultherapy PRIME's 35% larger screen and faster image refresh rate provide brighter, crisper images from all angles, ensuring a vivid visualization experience.

“The launch of Ultherapy PRIME demonstrates our commitment to persist in innovation,” said Bob Rhatigan, CEO, Merz Aesthetics. “As the leader in noninvasive lifting, we’re excited to bring Ultherapy PRIME to our customers as the next generation, premier platform and as a proven technology and customizable, long-lasting treatment option.”

Read more at Business Wire >>